Ascendis Pharma A/S (ASND) vs BridgeBio Pharma, Inc. (BBIO)

• Ascendis Pharma A/S ASND 255.84 ▲ +0.94%
• BridgeBio Pharma, Inc. BBIO 75.15 ▲ +1.18%

Ascendis Pharma A/S and BridgeBio Pharma, Inc. are both Biotechnology companies. Ascendis Pharma A/S is the larger, with a market value of $16.6B against $14.5B — 1.1× the size. BridgeBio Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Ascendis Pharma A/S trades at 18.3×. BridgeBio Pharma, Inc. grew revenue faster over the last twelve months: 167.3% against 126.0%. Ascendis Pharma A/S has the higher net margin (71.2% vs −62.6%) and the higher return on invested capital (15.1% vs 0.00%). Across the 17 metrics below, Ascendis Pharma A/S leads on 13 and BridgeBio Pharma, Inc. on 4.